...Biotech AG has raised a further CHF12.7 million ($13.9 million) in seed financing led by Pureos Bioventures...

...By Virginia Li Nearly half of Pureos Bioventures’ first fund, which closed this week at $170 million...
...$170 million, could be headed towards Swiss drug developers.The firm began investing its global BB Pureos Bioventures...

...Lava’s series C, which had participation from fellow new investors Redmile Group, Ysios Capital and BB Pureos Bioventures...

...firm were co-leader Kurma Partners as well as Pontifax, Droia Genetic Disease, Polaris Partners and Pureos Bioventures...

...detection of treatment failure or disease recurrence. Pureos invests in Basel incubator Swiss VC BB Pureos Bioventures...
...an undisclosed investment in the firm’s second therapeutics-focused fund. BioCentury Staff Simcere Pharmaceutical Group Lantern Pharma Inc. Cue Health Inc. Pureos Bioventures Sanofi Cathay...

...Bpifrance, CapDecisif and Inserm Transfert, as well as new investors Global Health Sciences Fund and Pureos BioVentures...

...investor Forbion Capital Partners and existing investors Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures...

...raised CHF12.5 million ($12.3 million) in a series A round co-led by BioMedPartners and BB Pureos Bioventures...